We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
-4.55%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$373M
AUM Growth
-$14.1M
Cap. Flow
-$75.1K
Cap. Flow %
-0.02%
Top 10 Hldgs %
45.1%
Holding
168
New
7
Increased
20
Reduced
35
Closed
4

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$283K
2
TMO icon
Thermo Fisher Scientific
TMO
+$176K
3
COF icon
Capital One
COF
+$139K
4
KMB icon
Kimberly-Clark
KMB
+$135K
5
ETSY icon
Etsy
ETSY
+$134K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$372K
2
COST icon
Costco
COST
+$179K
3
BR icon
Broadridge
BR
+$143K
4
PG icon
Procter & Gamble
PG
+$124K
5
ICE icon
Intercontinental Exchange
ICE
+$118K

Sector Composition

Rank Sector Weight
1 Technology 34.93%
2 Healthcare 13.25%
3 Financials 12.04%
4 Communication Services 11.95%
5 Consumer Staples 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAT icon
26
Applied Materials
AMAT
$417B
$4.97M 1.33%
35,868
– –
AFL icon
27
Aflac
AFL
$60.7B
$4.29M 1.15%
55,915
-125
-0.2% -$9.28K
CSCO icon
28
Cisco
CSCO
$475B
$3.7M 0.99%
68,858
– –
PG icon
29
Procter & Gamble
PG
$338B
$3.68M 0.99%
25,229
-810
-3% -$124K
CVX icon
30
Chevron
CVX
$386B
$3.58M 0.96%
21,257
+124
+0.6% +$20K
WWD icon
31
Woodward
WWD
$21.1B
$2.71M 0.73%
21,830
-250
-1% -$31.2K
HXL icon
32
Hexcel
HXL
$7.6B
$2.69M 0.72%
41,359
-950
-2% -$67.6K
MSFT icon
33
Microsoft
MSFT
$3.74T
$2.57M 0.69%
8,125
– –
CRM icon
34
Salesforce
CRM
$162B
$2.12M 0.57%
10,475
-300
-3% -$64.8K
JPM icon
35
JPMorgan Chase
JPM
$962B
$1.73M 0.46%
11,926
+160
+1% +$24K
ABBV icon
36
AbbVie
ABBV
$442B
$1.63M 0.44%
10,951
-100
-0.9% -$14.7K
RITM.PRB icon
37
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$284M
$1.57M 0.42%
69,716
-1,400
-2% -$31.3K
SHEL icon
38
Shell
SHEL
$250B
$1.44M 0.39%
22,423
– –
WFC.PRL icon
39
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.1M 0.29%
987
-40
-4% -$46.2K
VRSN icon
40
VeriSign
VRSN
$26B
$1.01M 0.27%
4,995
– –
SCHW
41
Charles Schwab
SCHW
$186B
$937K 0.25%
17,068
– –
EW icon
42
Edwards Lifesciences
EW
$54B
$918K 0.25%
13,250
– –
GILD icon
43
Gilead Sciences
GILD
$168B
$827K 0.22%
11,031
-100
-0.9% -$7.69K
AGNCO icon
44
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
$742K 0.2%
31,534
– –
DOW icon
45
Dow Inc
DOW
$22.6B
$732K 0.2%
14,199
-500
-3% -$26.8K
AVY icon
46
Avery Dennison
AVY
$13.6B
$603K 0.16%
3,300
-300
-8% -$54.3K
T.PRA icon
47
AT&T Series A
T.PRA
$859M
$597K 0.16%
29,300
– –
ABT icon
48
Abbott
ABT
$190B
$587K 0.16%
6,060
– –
ROST icon
49
Ross Stores
ROST
$80.8B
$565K 0.15%
5,000
– –
MCD icon
50
McDonald's
MCD
$194B
$551K 0.15%
2,090
+233
+13% +$66.5K
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return

Kelly Lawrence W & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Kelly Lawrence W & Associates held 168 positions worth $373M, down 3.7% from $387M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kelly Lawrence W & Associates's Q3 2023 filing shows 7 new, 20 increased, 35 reduced and 4 closed positions. Its largest new stake was Thermo Fisher Scientific: 330 shares worth $167K. The largest sale was Verizon, an estimated $372K.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q3 2023 buy was Thermo Fisher Scientific: 330 shares worth $167K.
  • Kelly Lawrence W & Associates added most to American Tower in Q3 2023, an estimated $283K increase.
  • Kelly Lawrence W & Associates's biggest Q3 2023 reduction was Verizon, cutting an estimated $372K.
  • Kelly Lawrence W & Associates fully exited CVS Health in Q3 2023, selling an estimated $53.9K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 45% of its $373M portfolio in Q3 2023.
  • Kelly Lawrence W & Associates opened 7 new positions and closed 4 in Q3 2023.
  • Kelly Lawrence W & Associates's portfolio value fell 3.7% quarter-over-quarter to $373M.

Based on Kelly Lawrence W & Associates's 13F filing for Q3 2023, filed 14 Nov 2023.